Preface
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
i-i
Author(s):
Alain Rolland
Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
1-9
Author(s):
A. J. Grillo-Lopez, C. A. White, B. K. Dallaire, C. L. Varns, C. D. Shen, A. Wei, J. E. Leonard, A. McClure, R. Weaver, S. Cairelli and J. Rosenberg
Growth Velocity, Final Height and Bone Mineral Metabolism of Short Children Treated Long Term with Growth Hormone
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
33-46
Author(s):
Roberto Lanes
Health Care Discovery, Novo Nordisk A/S, DK-2880 Bagsværd, Denmark
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
63-71
Author(s):
Esper Boel, Tatjana Albrektsen, Jan Fleckner and John Selmer
The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
73-82
Author(s):
Domenico Ribatti, Angelo Vacca, Luisa Roncali and Franco Dammacco
Current Status and Recent Developments in Anthracenone Antipsoriatics
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
901-918
Author(s):
Klaus Muller
Recent Developments in Receptor-Selective Retinoids
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
919-931
Author(s):
Sunil Nagpal and Roshantha A.S. Chandraratna
New Trends in Thromboxane and Prostacyclin Modulators
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
609-628
Author(s):
Jean -Michel Dogne, Xavier de Leval, Jacques Delarge, Jean -Louis David and Bernard initial Masereel
Mechanisms for the Selective Actions of Vitamin D Analogues
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
701-716
Author(s):
Alex J. Brown
New Synthetic Vitamin D Analogs with Antiproliferative Activities
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
767-789
Author(s):
Andreas Steinmeyer, Gerald Kirsch, Gunter Neef and Katica Schwarz